Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

/PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development,...

Related Keywords

Taiwan ,Japan ,Singapore ,United States ,Italy ,Italian ,Maurizio Luongo ,Menarini Asia Pacific ,Prnewswire Menarini Asia Pacific ,Institute For Health Metrics ,Consumer Health ,Men Health ,Menarini Group ,Global Burden Of Disease Collaborative Network ,Astellas Pharma Inc ,Astellas Pharma ,South East Asian ,Chief Executive Officer ,Global Burden ,Disease Collaborative ,Disease Study ,Health Metrics ,Specialty Care ,Financial Year ,Asia Pacific ,